TENX — structural market context
Tenax Therapeutics, Inc. Commo
Structural market context from public regulatory and market data, shown with its as-of dates. Descriptive only: nothing on this page is a recommendation, a prediction, or advice to buy or sell any security.
TENX short interest & days to cover
FINRA consolidated short interest, reported twice a month and published ~2 weeks after each settlement date. % of float uses reported free float. · as of 2026-07-31 (38d ago)
TENX fails-to-deliver (FTD)
| Settlement date | Failed shares | Price |
|---|
| 2026-08-14 · 24d | 911 | $1.83 |
| 2026-08-12 · 26d | 6K | $1.62 |
| 2026-08-11 · 27d | 825K | $1.38 |
SEC fails-to-deliver files, published twice a month with ~6 weeks of delay.
TENX insider buying and selling (Form 4)
Last 12 months, open-market only: 6 purchases · 0 sales
| Insider | Type | Shares | Value | Filed |
|---|
| ADAR1 Capital Management, LLC · 10 percent owner | Buy (P) | 404K | $723K | 2026-09-02 |
| ADAR1 Capital Management, LLC · 10 percent owner | Buy (P) | 179K | $322K | 2026-09-02 |
| ADAR1 Capital Management, LLC · 10 percent owner | Buy (P) | 188K | $338K | 2026-09-02 |
| ADAR1 Capital Management, LLC · 10 percent owner | Buy (P) | 202K | $360K | 2026-08-24 |
| ADAR1 Capital Management, LLC · 10 percent owner | Buy (P) | 716K | $1.3M | 2026-08-24 |
SEC Form 4 filings, open-market purchases and sales only (codes P and S); grants and option exercises excluded. Attributed public records.
TENX analyst ratings — with each firm's measured accuracy
| Firm | Action | Rating | Firm 5d hit rate* | Published |
|---|
| Citigroup | downgrade | Neutral | 37.3% (n=67) | 2026-08-31 |
| H.C. Wainwright | initialise | Buy | 37.5% (n=40) | 2026-08-31 |
| RBC Capital | initialise | Outperform | 54.3% (n=35) | 2026-08-31 |
| Roth Capital | initialise | Buy | n<30 | 2026-08-31 |
| BMO Capital | downgrade | Market Perform | 58.8% (n=34) | 2026-08-31 |
*Rating actions from public feeds. Where shown, the firm's 5-day hit rate is our measured backtest (firms with >=30 graded calls); a historical hit rate describes past calls, it does not grade this one.
Frequently asked questions
Are insiders buying TENX?
In the last 12 months of SEC Form 4 filings, TENX recorded 6 open-market insider purchases and 0 open-market sales (codes P and S; grants and option exercises excluded). These are attributed public records — information, not instruction.
What do analysts say about TENX?
The most recent action: Citigroup downgrade to Neutral on 2026-08-31. In our backtest, Citigroup's 5-day hit rate across 67 graded calls is 37.3%. We show each firm's measured record next to its ratings; a historical hit rate describes past calls and does not grade this one.
Is this page telling me to buy or sell TENX?
No. Everything on this page is descriptive, structural market context from public data, shown with its as-of dates. TradeAI News does not issue directional recommendations, price predictions, or buy/sell advice — for any ticker.